Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Novel antiplatelet approaches following acute coronary syndromes or percutaneous coronary intervention Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by